Development of early-diagnosis and made-to-order immunotherapy fororal cancers by using cancer-specific peptides
Project/Area Number |
20390518
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Kyushu University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
YOSHIDA Hiroki 佐賀大学, 医学部, 教授 (40260715)
YAMADA Akira 久留米大学, 先端癌治療センター, 教授 (50158177)
|
Project Period (FY) |
2008 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥15,340,000 (Direct Cost: ¥11,800,000、Indirect Cost: ¥3,540,000)
Fiscal Year 2011: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2010: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2009: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2008: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
|
Keywords | 癌 / 口腔癌 / 免疫療法 / T細胞 / ペプチド / 治療 / 診断 / 臨床 |
Research Abstract |
Fully understanding of immune surveillance and regulation against cancers is needed to develop early-diagnosis and made-to-order immunotherapy for cancers by using cancer-specific peptides. In this study, SART-1 was identified to have strongest antigenicity among various cancer-specific peptides expressed on oral cancersand to play a central part in immune surveillance against oral cancers, indicating that SART-1 is most promisingly applicable to the treatment and diagnosis of oral cancers.In contrast, it was revealed that a tumor-associated antigen, RCAS1, was expressed on and secreted from oral cancers, induced apoptosis of activated T cells, and thussuppressed immune surveillance against oral cancers. To augment immune surveillance against oral cancers, it was strongly suggested that functional regulation of RCAS1, as well as inoculation of SART-1, should be achieved.
|
Report
(6 results)
Research Products
(15 results)
-
[Journal Article] In vitro induction of specific CD8(+) T lymphocytes by tumorassociated antigenic peptides in patients with oral squamous cell carcinoma2012
Author(s)
Toyoshima, T., Kumamaru, W., Hayashida, J.-N., Moriyama, M., Kitamura, R., Tanaka, H., Yamada, A., Itoh, K., and Nakamura, S.
-
Journal Title
Cancer Lett
Volume: 322
Issue: 1
Pages: 86-91
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma2011
Author(s)
Matsubara, R., Kawano, S., Kiyosue, T., Goto, Y., Hirano, M., Jinno, T.,Toyoshima, T., Kitamura, R., Oobu, K., and Nakamura S
-
Journal Title
Int. J. Oncol
Volume: 39
Pages: 1391-9
DOI
Related Report
-
-
-
-
-
-
-
-
-
-
[Presentation] Possible involvement of ΔNp63 in proliferation and differentiation of OSCC2010
Author(s)
Matsubara, R., Kawano, S., Kiyosue, T., Goto, Y., Nakao, Y., Yoshiga, D., Oobu, K., and Nakamura S
Organizer
10thBiennial Congress of the European Association of Oral Medicine
Place of Presentation
London
Year and Date
2010-09-23
Related Report
-
-